Isolation, Characterization, and Immunological Detection of Neutrophil-activating Peptide 2: a Proteolytic Degradation Product of Platelet Basic Protein
Overview
General Medicine
Physiology
Authors
Affiliations
Neutrophil-activating peptide 2 (NAP-2), corresponding to platelet basic protein fragment 25-94, was prepared by chymotryptic digestion of its precursors, low affinity platelet factor 4 or beta-thromboglobulin, followed by purification by high performance liquid chromatography. NAP-2 (0.1-1.5 microns) caused the release of human granulocyte elastase from cytochalasin B-treated neutrophils in a dose-dependent manner. In the same system, beta-thromboglobulin, human platelet factor 4, S-pyridylethyl NAP-2, and platelet basic protein C-terminal fragment (77-94) were inactive, whereas platelet basic protein fragment 22-89 had low, but significant, activity. Sensitive immunological identification of NAP-2 based on nonequilibrium isoelectric focusing and immunoblotting is described.
NMR structure and dynamics of monomeric neutrophil-activating peptide 2.
Young H, Roongta V, Daly T, Mayo K Biochem J. 1999; 338 ( Pt 3):591-8.
PMID: 10051427 PMC: 1220091.
Stadnicki A, Gonciarz M, Niewiarowski T, Hartleb J, Rudnicki M, Merrell N Dig Dis Sci. 1997; 42(11):2356-66.
PMID: 9398817 DOI: 10.1023/a:1018891323205.
Mayo K, Yang Y, Daly T, Barry J, La Rosa G Biochem J. 1994; 304 ( Pt 2):371-6.
PMID: 7998970 PMC: 1137503. DOI: 10.1042/bj3040371.